Cargando…
A Supporting System for Management of Patients with Inflammatory Bowel Disease during COVID-19 Outbreak: Iranian Experience-Study Protocol
BACKGROUND The COVID-19 pandemic has affected the health care infrastructure dramatically, with abundant resources necessarily being redirected to COVID-19 patients and their care. Also, patients with chronic diseases like inflammatory bowel disease (IBD) may be affected in several ways during this...
Autores principales: | Anushiravani, Amir, Vahedi, Homayoon, Fakheri, Hafez, Mansour-ghanaei, Fariborz, Maleki, Iradj, Nasseri-Moghaddam, Siavosh, Vosoghinia, Hasan, Ghadir, Mohammad Reza, Hormati, Ahmad, Aminisani, Nayyereh, Radmard, Amir Reza, Khosravi, Bardia, Saberzadeh-Ardestani, Bahar, Malekzadeh, Masoud, Alatab, Sudabeh, Sadeghi, Anahita, Salahi, Sarvenaz, Malekzadeh, Reza, Sima, Ali Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Association of Gastroerterology and Hepatology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859612/ https://www.ncbi.nlm.nih.gov/pubmed/33564380 http://dx.doi.org/10.34172/mejdd.2020.188 |
Ejemplares similares
-
Susceptibility of Patients with Inflammatory Bowel Disease to COVID-19 Compared with Their Households
por: Anushiravani, Amir, et al.
Publicado: (2022) -
Efficacy of Anti-TNF Therapy for the Treatment of Patients with Moderate-to-Severe Inflammatory Bowel Disease; a First Iranian Report
por: Mohagheghi Darehranj, Samaneh, et al.
Publicado: (2020) -
Iranian Consensus Guideline for Pharmacotherapy with Biologics and Small Molecules Drugs in Adults with Inflammatory Bowel Diseases
por: Khoshnam-Rad, Niloofar, et al.
Publicado: (2023) -
Minimum Requirements for Reporting Fecal Microbiota Transplant Trial
por: Moossavi, Shirin, et al.
Publicado: (2015) -
Diagnostic Accuracy of Age and Alarm Symptoms for Upper GI Malignancy in Patients with Dyspepsia in a GI Clinic: A 7-Year Cross-Sectional Study
por: Khademi, Hooman, et al.
Publicado: (2012)